See the DrugPatentWatch profile for pravastatin

After conducting a thorough analysis based on the available information, it can be concluded that Pravastatin and Lipitor are both effective in treating high cholesterol, but Pravastatin may be more cost-effective.

Pravastatin is a statin medication used to treat high cholesterol and prevent cardiovascular disease. It is available as a generic drug, which typically makes it less expensive than brand-name medications [1]. Lipitor, also a statin, is a brand-name medication used to treat high cholesterol and reduce the risk of heart attack and stroke. While Lipitor has been a popular and effective treatment option for many years, it is more expensive than Pravastatin due to its status as a brand-name drug [2].

According to DrugPatentWatch.com, Pravastatin's patent expired in 2006, which has led to increased competition among generic manufacturers and subsequently lower prices [3]. On the other hand, Lipitor's patent expired in 2011, but it still tends to be more expensive than Pravastatin [4].

It is important to note that cost-effectiveness is not solely determined by the list price of a medication. Other factors, such as insurance coverage, dosage, and treatment duration, can impact the overall cost of a medication. Patients should consult with their healthcare providers and insurance companies to determine the most cost-effective treatment option for their specific situation.

In summary, based on the available information, Pravastatin is generally more cost-effective than Lipitor for treating high cholesterol due to its lower price as a generic medication. However, patients should consider various factors when determining the most cost-effective treatment option for their specific situation.

Sources:

1. "Pravastatin." Mayo Clinic, Mayo Foundation for Medical Education and Research, 21 Jan. 2022, [www.mayoclinic.org/drugs-supplements/pravastatin-oral-route/description/drg-20064003](http://www.mayoclinic.org/drugs-supplements/pravastatin-oral-route/description/drg-20064003).
2. "Atorvastatin (Oral Route)." Mayo Clinic, Mayo Foundation for Medical Education and Research, 21 Jan. 2022, [www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20063554](http://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20063554).
3. "Pravastatin." DrugPatentWatch, [www.drugpatentwatch.com/drugs/pravastatin](http://www.drugpatentwatch.com/drugs/pravastatin).
4. "Atorvastatin." DrugPatentWatch, [www.drugpatentwatch.com/drugs/atorvastatin](http://www.drugpatentwatch.com/drugs/atorvastatin).